Home » GC News & Media
GC News & Media
Advocates and journalists can find out the latest news through our electronic newsletter, media articles, press releases, and download center. Or contact us to discuss the field.
GCM quoted in Kenya's Daily Nation newspaper article on the need to increase research and funding for microbicides as an HIV prevention tool for women: http://www.nation.co.ke/Features/Living/The+power+to+protect+and+to+plan/-/1218/1281392/-/12rklfa/-/index.html
Read the GCM statement on the November 17, 2011 VOICE DSMB decision
Read GCM statement on VOICE trial DSMB decision
Read GCM statement on the 13 July 2011 release of PrEP results
Read GCM statement on the discontinuation of the FEM-PrEP trial
Read GCM iPrEx press release
Read GCM statement on Tenofovir-gel FDA decision
Read about a modeling study on mass rape in armed conflict areas
MTN is testing the rectal use of tenofovir gel for safety and acceptability. The new study will enroll 60 men and women across three U.S. sites. (more)
Learn about the CAPRISA 004 trial results
Our electronic newsletter, GCNews, is a compilation of articles covering news about the microbicides and HIV-prevention technologies field. Melissa May, GCM’s Director of Communications, is the editor-in-chief, with articles being written by GCM staff and colleagues.
Media Inquiries - for more information and interviews
Press Releases - GCM's press releases
Staff Biographies - learn more about the GCM staff members
Quick Quotes - public statements
Key publications - published articles & publications
GCM in the Media - as a prominent member of the microbicides advocacy community, GCM is often asked to contribute writing, interviews and input to media and journal articles.
Events - learn about GCM’s presence at events, trainings, and conferences
Video - a sampling of videos featuring GCM and new HIV-prevention methods